Wednesday August 22, 2018
Home Life Style Health & Fitness Esteé Lauder&...

Esteé Lauder’s Breast Cancer Awareness ‘Pink Ribbon Campaign’ Marks 25 Year Milestone

The campaign gives hope to all the women who have breast cancer and unites them with a single thread of hope and shows them that they are not alone

0
//
56
Pink Ribbon Campaign
Breast Cancer. Pixabay
Republish
Reprint

Oct 1, 2017: Breast Cancer is the second most leading cause of death by among women. The chances of a woman dying from breast cancer are 1 in 37. There is a dire need to spread awareness about breast cancer. Though the deaths from breast cancer have reduced from 1980 till 2007, there is still a lot more work needs that to be done.

The breast cancer awareness was started by Charlotte Hayley, who had battled breast cancer. She brought in the concept of using a peach color breast cancer awareness ribbon. The peach colored ribbon piqued the interest of the editor of the Self magazine, Alexandra Penney, who was then working on the 1992 National Breast Cancer Awareness Month issue. He offered Charlotte to work with her idea, but Charlotte rejected saying that the proposal would make her awareness drive too commercial. Unable to use the peach ribbon, the Self Magazine and the other people who were interested in promoting breast cancer awareness decide to use the pink color. This was the beginning of the concept to use a pink ribbon to promote awareness and thus the idea for pink ribbon campaign.

The pink ribbon has been a symbol of fear of cancer, hope for the future and the goodness of the people who support the awareness programme. It has been the empowering symbol for millions for the past 25 years.  Some organizations like the Pink Ribbon International use the pink ribbon as their primary logo. The pink ribbon, ever since it was created has been helping people to live through and beyond breast cancer by supporting and encouraging them.

Also Read: Pregnancy seems Safe for Breast Cancer Survivors: Study

The campaign today is active in over 70 countries including India and has collaborated with more than 60 regional organizations to provide help in the most needed areas. The activity of the campaign has led to a 38% decrease in breast cancer mortality rates.

To celebrate the success of their campaign, Esteé Lauder has decided to launch their Pink Ribbon inspired collection of cosmetics. 20% of the profits will be donated to research in the field of curing breast cancer. The Pink Ribbon campaign is no longer only a breast cancer awareness drive, but it has become the symbol of the women who have gone through it and have come out of this stronger. This campaign gives hope to all the women who have breast cancer and unites them with a single thread of hope and shows them that they are not alone.

The Pink Campaign is a tribute to its late founder Evelyn Lauder who first launched the pink ribbon. The pink ribbon today has crossed the 25-year milestone, and to honor the 25th anniversary, the Esteé Lauder Companies have decided on a new mission: To create a breast cancer-free world.  25 years ago, Evelyn Lauder saw women dying of breast cancer, and there was nothing done to prevent it. Thus she became the pioneer of the Pink Ribbon campaign which eventually became the global leader in breast cancer awareness.

Prepared by Saloni Hindocha of Newsgram

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Multi-gene Test May Help to Diagnose The Risk of Heart Disease, Diabetes And More

But specialists in heart disease and genetics who weren’t involved with the research called the new findings exciting because of their scope

0
Gene test
Stephanie Richurk, a nurse at the University of Pittsburgh Medical Center, sorts blood samples collected from participants in the "All of Us" research program in Pittsburgh, Aug. 7, 2017. (VOA)

You know your cholesterol, your blood pressure … your heart gene score? Researchers say a new way of analyzing genetic test data may one day help identify people at high risk of a youthful heart attack in time to help.

Today, gene testing mostly focuses on rare mutations in one or a few genes, like those that cause cystic fibrosis or sickle cell disease, or the BRCA gene responsible for a small fraction of breast cancer. It is less useful for some of the most common diseases, such as heart disease or diabetes, because they are influenced by vast numbers of genes-gone-wrong working together in complicated ways.

Monday, researchers reported a new way to measure millions of small genetic variations that add up to cause harm, letting them calculate someone’s inherited risk for the most common form of heart disease and four other serious disorders. The potential cardiac impact: They estimated that up to 25 million Americans may have triple the average person’s risk for coronary artery disease even if they haven’t yet developed warning signs like high cholesterol.

“What I foresee is in five years, each person will know this risk number, this ‘polygenic risk score,’ similar to the way each person knows his or her cholesterol,” said Dr. Sekar Kathiresan who led the research team from the Broad Institute, Massachusetts General Hospital and Harvard Medical School.

If the approach pans out and doctors adopt it, a bad score wouldn’t mean you’d get a disease, just that your genetic makeup increases the chance — one more piece of information in deciding care. For example, when the researchers tested the system using a DNA database from Britain, less than 1 percent of people with the lowest risk scores were diagnosed with coronary artery disease, compared to 11 percent of people with the highest risk score.

heart disease
Multi-gene Test May Find Risk for Heart Disease and More. Pixabay

“There are things you can do to lower the risk,” Kathiresan said — the usual advice about diet, exercise, cholesterol medication and not smoking helps.

On the flip side, a low-risk score “doesn’t give you a free pass,” he added. An unhealthy lifestyle could overwhelm the protection of good genes.

The scoring system also can predict an increased risk of Type 2 diabetes, inflammatory bowel disease, breast cancer and an irregular heartbeat called atrial fibrillation, the team reported in the journal Nature Genetics — noting that next steps include learning what might likewise lower those risks.

It doesn’t require the most sophisticated type of genetic testing. Instead, Kathiresan can calculate risk scores for those five diseases — eventually maybe more — simply by reanalyzing the kind of raw data people receive after sending a cheek swab to companies like 23andMe.

A geneticist who specializes in cardiovascular disease, he hopes to open a website where people can send in such data to learn their heart risk, as part of continuing research. Kathiresan and co-author Dr. Amit Khera, a Mass General cardiologist, are co-inventors on a patent application for the system.

Other scientists and companies have long sought ways to measure risk from multiple, additive gene effects — the “poly” in polygenic — and Myriad Genetics has begun selling a type of polygenic test for breast cancer risk.

But specialists in heart disease and genetics who weren’t involved with the research called the new findings exciting because of their scope.

Cancer
Cancer Ribbon. Pixabay

“The results should be eye-opening for cardiologists,” said Dr. Charles C. Hong, director of cardiovascular research at the University of Maryland School of Medicine. “The only disappointment is that this score applies only to those with European ancestry, so I wonder if similar scores are in the works for the large majority of the world population that is not white.”

Hong pointed to a friend who recently died of a massive heart attack despite being a super-fit marathon runner who’d never smoked, the kind of puzzling death that doctors have long hoped that a better understanding of genetics could help to prevent.

“Most of the variation in disease risk comes from an enormous number of very tiny effects” in genes, agreed Stanford University genetics professor Jonathan Pritchard. “This is the first time polygenic scores have really been shown to reach the level of precision where they can have an impact” on patient health.

Also Read- Tdap Vaccinations Do Not Pose a Risk of Autism

First, the Boston-based team combed previous studies that mapped the DNA of large numbers of people, looking for links to the five diseases — not outright mutations but minor misspellings in the genetic code.

Each variation alone would have only a tiny effect on health. They developed a computerized system that analyzed how those effects add up, and tested it using DNA and medical records from 400,000 people stored in Britain’s UK Biobank. Scores more than three times the average person’s risk were deemed high. (VOA)